Ying Fu

1.2k total citations
19 papers, 704 citations indexed

About

Ying Fu is a scholar working on Epidemiology, Molecular Biology and Nephrology. According to data from OpenAlex, Ying Fu has authored 19 papers receiving a total of 704 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Epidemiology, 6 papers in Molecular Biology and 3 papers in Nephrology. Recurrent topics in Ying Fu's work include Liver Disease Diagnosis and Treatment (3 papers), Acute Kidney Injury Research (3 papers) and T-cell and B-cell Immunology (3 papers). Ying Fu is often cited by papers focused on Liver Disease Diagnosis and Treatment (3 papers), Acute Kidney Injury Research (3 papers) and T-cell and B-cell Immunology (3 papers). Ying Fu collaborates with scholars based in China, United States and United Kingdom. Ying Fu's co-authors include Alex Renn, Guy J. Clarkson, Matthew D. Hall, Peter J. Sadler, Zheng Dong, Abraha Habtemariam, Chengyuan Tang, Anton Simeonov, Xin Hu and Wayne A. Marasco and has published in prestigious journals such as Nature Communications, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Ying Fu

18 papers receiving 697 citations

Peers

Ying Fu
June Ereño‐Orbea Spain
Praveen K. Madala Australia
Qing Liang China
János Pató Hungary
Kimio Mizuno Japan
Martin Hibbs United Kingdom
Maria V. Papadopoulou United States
Oliver S. Thomas Germany
Shiyong Fan China
Jacintha Shenton United States
June Ereño‐Orbea Spain
Ying Fu
Citations per year, relative to Ying Fu Ying Fu (= 1×) peers June Ereño‐Orbea

Countries citing papers authored by Ying Fu

Since Specialization
Citations

This map shows the geographic impact of Ying Fu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Fu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Fu more than expected).

Fields of papers citing papers by Ying Fu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Fu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Fu. The network helps show where Ying Fu may publish in the future.

Co-authorship network of co-authors of Ying Fu

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Fu. A scholar is included among the top collaborators of Ying Fu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Fu. Ying Fu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
2.
Fu, Ying, et al.. (2025). Lipid metabolism in AKI and AKI-CKD transition: Dysregulation, lipotoxicity and therapeutic potential. Pharmacology & Therapeutics. 275. 108930–108930. 1 indexed citations
3.
Wang, Ying, Yuqing Zeng, Ying Fu, et al.. (2025). Repression of peroxisome proliferation-activated receptor γ coactivator-1α by p53 after kidney injury promotes mitochondrial damage and maladaptive kidney repair. Kidney International. 107(5). 869–887. 5 indexed citations
4.
5.
Fu, Ying, et al.. (2023). Autophagy in acute kidney injury and maladaptive kidney repair. Burns & Trauma. 11. tkac059–tkac059. 17 indexed citations
6.
Liao, Caizhi, Xiaofeng Chen, & Ying Fu. (2023). Salivary Analysis: An Emerging Paradigm for Non‐Invasive Healthcare Diagnosis and Monitoring (3/2023). 1(3). 6 indexed citations
7.
Shao, Min, Xiaojuan Chen, Fang Yang, et al.. (2022). Design, Synthesis, and Biological Evaluation of Aminoindazole Derivatives as Highly Selective Covalent Inhibitors of Wild-Type and Gatekeeper Mutant FGFR4. Journal of Medicinal Chemistry. 65(6). 5113–5133. 25 indexed citations
8.
Huang, Huichao, Xujun Liang, Ying Fu, et al.. (2022). Afatinib Reverses EMT via Inhibiting CD44-Stat3 Axis to Promote Radiosensitivity in Nasopharyngeal Carcinoma. Pharmaceuticals. 16(1). 37–37. 49 indexed citations
9.
Wang, Ying, Jiefu Zhu, Zhiwen Liu, et al.. (2020). The PINK1/PARK2/optineurin pathway of mitophagy is activated for protection in septic acute kidney injury. Redox Biology. 38. 101767–101767. 131 indexed citations
10.
Renn, Alex, Ying Fu, Xin Hu, Matthew D. Hall, & Anton Simeonov. (2020). Fruitful Neutralizing Antibody Pipeline Brings Hope To Defeat SARS-Cov-2. Trends in Pharmacological Sciences. 41(11). 815–829. 79 indexed citations
11.
Zhu, Wenli, Zhen Wang, Ye Gong, et al.. (2019). Human C5-specific single-chain variable fragment ameliorates brain injury in a model of NMOSD. Neurology Neuroimmunology & Neuroinflammation. 6(3). e561–e561. 8 indexed citations
12.
He, Aiwu Ruth, Bhaskar Kallakury, Deborah L. Berry, et al.. (2018). Detection of a lipid peroxidation-induced DNA adduct across liver disease stages. HepatoBiliary Surgery and Nutrition. 7(2). 85–97. 10 indexed citations
13.
Feng, Mingqian, He-jiao Bian, Xiaolin Wu, et al.. (2018). Construction and next-generation sequencing analysis of a large phage-displayed VNAR single-domain antibody library from six naïve nurse sharks. PubMed. 2(1). 1–11. 62 indexed citations
14.
Avnir, Yuval, Corey T. Watson, Jacob Glanville, et al.. (2016). IGHV1-69 polymorphism modulates anti-influenza antibody repertoires, correlates with IGHV utilization shifts and varies by ethnicity. Scientific Reports. 6(1). 20842–20842. 122 indexed citations
15.
Fu, Ying, Zhen Zhang, Jared Sheehan, et al.. (2016). A broadly neutralizing anti-influenza antibody reveals ongoing capacity of haemagglutinin-specific memory B cells to evolve. Nature Communications. 7(1). 12780–12780. 64 indexed citations
16.
Fu, Ying, Rina Soni, María J. Romero, et al.. (2013). Mirror‐Image Organometallic Osmium Arene Iminopyridine Halido Complexes Exhibit Similar Potent Anticancer Activity. Chemistry - A European Journal. 19(45). 15199–15209. 40 indexed citations
17.
Fu, Ying, Abraha Habtemariam, Aida M. Basri, et al.. (2011). Structure–activity relationships for organometallic osmium arene phenylazopyridine complexes with potent anticancer activity. Dalton Transactions. 40(40). 10553–10553. 70 indexed citations
18.
Wu, Wei, Minhua Chen, Ying Fu, et al.. (2010). [Long-term efficacy of radiofrequency ablation in 446 patients with hepatocellular carcinoma].. PubMed. 42(6). 716–21. 1 indexed citations
19.
Wang, Rui, Ying Fu, Qing Zhao, Lin Pan, & Wei Zhang. (2009). Human Fcα/μR and pIgR distribute differently in intestinal tissues. Biochemical and Biophysical Research Communications. 381(2). 148–152. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by June Ereño‐Orbea Breakdown of academic impact, for papers by Praveen K. Madala Breakdown of academic impact, for papers by Qing Liang Breakdown of academic impact, for papers by János Pató Breakdown of academic impact, for papers by Kimio Mizuno Breakdown of academic impact, for papers by Martin Hibbs Breakdown of academic impact, for papers by Maria V. Papadopoulou Breakdown of academic impact, for papers by Oliver S. Thomas Breakdown of academic impact, for papers by Shiyong Fan Breakdown of academic impact, for papers by Jacintha Shenton
Rankless by CCL
2026